CBD is really a CB1 antagonist that has a weak affinity to the CB1 receptor, indicating it doesn’t bind really strongly. From the pharmacological point of view, it’s similar to THC, plus the really limited exploration that has been accomplished on it indicates it's got related consequences, just with reduced https://thcdisposables.co.uk/